Price $386.22 |
Market Cap
21.67B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
36.0
|
P/B
95.83
|
P/S
8.82
|
Dividend %
-
|
|
P/CF
75.8
|
P/FCF
31.9
|
Op. Cash Flow
857.3K
|
FCF
11.1
|
|
Op. Margin
29.80%
|
Net Margin
24.60%
|
ROE
-
|
ROI
35.00%
|
|
ROA
21.70%
|
EPS Growth
21.10%
|
Current Ratio
1.7
|
Debt/Equity
519.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $29.59 | - | - | 10.52B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $68.15 | - | 2.90% | 148.62B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.53 | - | - | 15.2M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.13 | - | - | 60.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
